Qi L, Meijler MM, Lee SH, Sun C, Janda KD (2004) Solid-phase synthesis of anandamide analogues. Org Lett 6: 1673-1675

Qin C, Lin S, Lang W, Goutopoulos A, Pavlopoulos S, Mauri F, Makriyannis A (1998) Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography. Anal Biochem 261: 8-15

Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP, Jr. (2003) Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99: 955-960

Qui MS, Green SH (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9: 705-717

Quinn G, Langford G (2001) The porcine endogenous retrovirus long terminal repeat contains a single nucleotide polymorphism that confers distinct differences in estrogen receptor binding affinity between PERV A and PERV B/C subtypes. Virology 286: 83-90

Quinn KE, Ehrlich BE (1997) Methanethiosulfonate derivatives inhibit current through the ryanodine receptor/channel. J Gen Physiol 109: 255-264

Quistad GB, Nomura DK, Sparks SE, Segall Y, Casida JE (2002) Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides. Toxicol Lett 135: 89-93

Quistad GB, Sparks SE, Casida JE (2001) Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. Toxicol Appl Pharmacol 173: 48-55

Quistad GB, Sparks SE, Segall Y, Nomura DK, Casida JE (2002) Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications. Toxicol Appl Pharmacol 179: 57-63

Qureshi J, Saady M, Cardounel A, Kalimi M (1998) Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol. Mol Cell Biochem 181: 21-27

Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A (2003) A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23: 2453-2458

Rademacher DJ, Patel S, Hopp FA, Dean C, Hillard CJ, Seagard JL (2003) Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. Am J Physiol Heart Circ Physiol 284: H1570-1576

Raffa RB, Stone DJ, Jr., Hipp SJ (1999) Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice. Neurosci Lett 263: 29-32

Raghupathi R, Graham DI, McIntosh TK (2000) Apoptosis after traumatic brain injury. J Neurotrauma 17: 927-938

Rakhshan F, Day TA, Blakely RD, Barker EL (2000) Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292: 960-967

Raku T, Kitagawa M, Shimakawa H, Tokiwa Y (2003) Enzymatic synthesis of trehalose esters having lipophilicity. J Biotechnol 100: 203-208

Ralevic V (2003) Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol 472: 1-21

Ralevic V, Kendall DA (2001) Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed. Eur J Pharmacol 418: 117-125

Ralevic V, Kendall DA (2002) Cannabinoids inhibit pre- and postjunctionally sympathetic neurotransmission in rat mesenteric arteries. Eur J Pharmacol 444: 171-181

Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, Smart D (2001) Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur J Pharmacol 424: 211-219

Ralevic V, Kendall DA, Randall MD, Smart D (2002) Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci 71: 2577-2594

Ramakrishnan M, Swamy MJ (1998) Differential scanning calorimetric studies on the thermotropic phase transitions of N-acylethanolamines of odd chainlengths. Chemistry and Physics of Lipids 94: 43-51

Ramakrishnan M, Swamy MJ (1999) Molecular packing and intermolecular interactions in N-acylethanolamines: crystal structure of N-myristoylethanolamine. Biochim Biophys Acta 1418: 261-267

Ramer R, Brune K, Hinz B (2003) Ceramide confers cannabinoid-induced COX-2 expression in human neuroglioma cells. Naunyn-Schmiedeberg's Archives of Pharmacology 367

Ramer R, Brune K, Pahl A, Hinz B (2001) R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun 286: 1144-1152

Ramer R, Brune K, Pahl A, Hinz B (2002) Induction of COX-2 expression by R(+)-methanandamide in human neuroglioma cells involves activation of p38 and p42/44 MAPK signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology 365

Ramer R, Weinzierl U, Schwind B, Brune K, Hinz B (2003) Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Mol Pharmacol 64: 1189-1198

Ramos-Franco J, Bare D, Caenepeel S, Nani A, Fill M, Mignery G (2000) Single-channel function of recombinant type 2 inositol 1,4, 5-trisphosphate receptor. Biophys J 79: 1388-1399

Ramos-Franco J, Fill M, Mignery GA (1998) Isoform-specific function of single inositol 1,4,5-trisphosphate receptor channels. Biophys J 75: 834-839

Randall MD (1999) The cardiovascular actions of cannabinoids: More questions than answers. British Journal of Pharmacology 128

Randall MD (2003) A new endothelial target for cannabinoids. Mol Pharmacol 63: 469-470

Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA (1996) An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229: 114-120

Randall MD, Kendall DA (1997) Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335: 205-209

Randall MD, Kendall DA (1998) Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. Eur J Pharmacol 346: 51-53

Randall MD, Kendall DA (1998) Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 19: 55-58

Randall MD, McCulloch AI, Kendall DA (1997) Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur J Pharmacol 333: 191-197

Randriamampita C, Giaume C, Neyton J, Trautmann A (1988) Acetylcholine-induced closure of gap junction channels in rat lacrimal glands is probably mediated by protein kinase C. Pflugers Arch 412: 462-468

Ransom BR, Neale E, Henkart M, Bullock PN, Nelson PG (1977) Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties. J Neurophysiol 40: 1132-1150

Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubrie P (2003) Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 284: R345-353

Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28: 640-648

Rawls SM, Cabassa J, Geller EB, Adler MW (2002) CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)- 6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther 301: 963-968

Rayman N, Lam KH, Laman JD, Simons PJ, Lowenberg B, Sonneveld P, Delwel R (2004) Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status. J Immunol 172: 2111-2117

Razdan RK, Mahadevan A (2002) Recent advances in the synthesis of endocannabinoid related ligands. Chem Phys Lipids 121: 21-33

Reale V, Chatwin HM, Evans PD (2004) The activation of G-protein gated inwardly rectifying K+ channels by a cloned Drosophila melanogaster neuropeptide F-like receptor. Eur J Neurosci 19: 570-576

Reale V, Hannan F, Hall LM, Evans PD (1997) Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists. J Neurosci 17: 6545-6553

Reaves BJ, Row PE, Bright NA, Luzio JP, Davidson HW (2000) Loss of cation-independent mannose 6-phosphate receptor expression promotes the accumulation of lysobisphosphatidic acid in multilamellar bodies. J Cell Sci 113 (Pt 22): 4099-4108

Reche I, Ruiz-Gayo M, Fuentes JA (1998) Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice. Neuropharmacology 37: 215-222

Recht LD, Salmonsen R, Rosetti R, Jang T, Pipia G, Kubiatowski T, Karim P, Ross AH, Zurier R, Litofsky NS, Burstein S (2001) Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochem Pharmacol 62: 755-763

Reckless J, Grainger DJ (1999) Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines. Biochem J 340 (Pt 3): 803-811

Reddy JV, Seaman MN (2001) Vps26p, a component of retromer, directs the interactions of Vps35p in endosome-to-Golgi retrieval. Mol Biol Cell 12: 3242-3256

Reddy PV, Natarajan V, Schmid PC, Schmid HH (1983) N-Acylation of dog heart ethanolamine phospholipids by transacylase activity. Biochim Biophys Acta 750: 472-480

Reddy PV, Schmid PC, Natarajan V, Schmid HH (1983) The role of cardiolipin as an acyl donor in dog heart N-acylethanolamine phospholipid biosynthesis. Biochim Biophys Acta 751: 241-246

Redmer A, Kathmann M, Schlicker E (2003) Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged mice. Br J Pharmacol 138: 1425-1430

Reeves DC, Goren EN, Akabas MH, Lummis SC (2001) Structural and electrostatic properties of the 5-HT3 receptor pore revealed by substituted cysteine accessibility mutagenesis. J Biol Chem 276: 42035-42042

Reeves DC, Sayed MF, Chau PL, Price KL, Lummis SC (2003) Prediction of 5-HT3 receptor agonist-binding residues using homology modeling. Biophys J 84: 2338-2344

Reggio PH (1999) Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors: achievements and challenges. Curr Med Chem 6: 665-683

Reggio PH (2002) Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids 66: 143-160

Reggio PH (2003) Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors. Curr Pharm Des 9: 1607-1633

Reggio PH, Basu-Dutt S, Barnett-Norris J, Castro MT, Hurst DP, Seltzman HH, Roche MJ, Gilliam AF, Thomas BF, Stevenson LA, Pertwee RG, Abood ME (1998) The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes. J Med Chem 41: 5177-5187

Reggio PH, Bramblett RD, Yuknavich H, Seltzman HH, Fleming DN, Fernando SR, Stevenson LA, Pertwee RG (1995) The design, synthesis and testing of desoxy-CBD: further evidence for a region of steric interference at the cannabinoid receptor. Life Sci 56: 2025-2032

Reggio PH, Traore H (2000) Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. Chem Phys Lipids 108: 15-35

Reggio PH, Wang T, Brown AE, Fleming DN, Seltzman HH, Griffin G, Pertwee RG, Compton DR, Abood ME, Martin BR (1997) Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. J Med Chem 40: 3312-3318

Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379: R1-2

Reich CG, Alger BE (2003) Magnitude and kinetics of endocannabinoid release in hippocampus induced by theta - burst trains of action potentials. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Reik W, Davies K, Dean W, Kelsey G, Constancia M (2001) Imprinted genes and the coordination of fetal and postnatal growth in mammals. Novartis Found Symp 237: 19-31; discussion 31-42

Reisert J, Matthews HR (1998) Na+-dependent Ca2+ extrusion governs response recovery in frog olfactory receptor cells. J Gen Physiol 112: 529-535

Reisert J, Matthews HR (1999) Adaptation of the odour-induced response in frog olfactory receptor cells. J Physiol 519 Pt 3: 801-813

Reisert J, Matthews HR (2000) Adaptation-induced changes in sensitivity in frog olfactory receptor cells. Chem Senses 25: 483-486

Reisert J, Matthews HR (2001) Response properties of isolated mouse olfactory receptor cells. J Physiol 530: 113-122

Reisert J, Matthews HR (2001) Responses to prolonged odour stimulation in frog olfactory receptor cells. J Physiol 534: 179-191

Reisert J, Matthews HR (2001) Simultaneous recording of receptor current and intraciliary Ca2+ concentration in salamander olfactory receptor cells. J Physiol 535: 637-645

Relvas JB, Setzu A, Baron W, Buttery PC, LaFlamme SE, Franklin RJ, ffrench-Constant C (2001) Expression of dominant-negative and chimeric subunits reveals an essential role for beta1 integrin during myelination. Curr Biol 11: 1039-1043

Resende AC, Ballejo G, Salgado MC (1998) Role of non-nitric oxide non-prostaglandin endothelium-derived relaxing factor(s) in bradykinin vasodilation. Braz J Med Biol Res 31: 1229-1235

Reynolds DS, Carter RJ, Morton AJ (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 18: 10116-10127

Reynolds L, Jones K, Winton DJ, Cranston A, Houghton C, Howard L, Ponder BA, Smith DP (2001) C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET. Oncogene 20: 3986-3994

Rhee MH (2002) Functional role of serine residues of transmembrane dopamin VII in signal transduction of CB2 cannabinoid receptor. J Vet Sci 3: 185-191

Rhee MH, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z (1998) Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem 71: 1525-1534

Rhee MH, Kim SK (2002) SR144528 as inverse agonist of CB2 cannabinoid receptor. J Vet Sci 3: 179-184

Rhee MH, Nevo I, Bayewitch ML, Zagoory O, Vogel Z (2000) Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. J Neurochem 75: 2485-2491

Rhee MH, Nevo I, Levy R, Vogel Z (2000) Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor. FEBS Lett 466: 300-304

Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, Breuer A, Mechoulam R (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40: 3228-3233

Rice AS, Farquhar-Smith WP, Nagy I (2002) Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 66: 243-256

Rice OV, Gordon N, Gifford AN (2002) Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice. Brain Res 945: 135-138

Rice W, Shannon JM, Burton F, Fiedeldey D (1997) Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone. Eur J Pharmacol 327: 227-232

Richard-Parpaillon L, Heligon C, Chesnel F, Boujard D, Philpott A (2002) The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus. Dev Biol 244: 407-417

Richardson JD, Aanonsen L, Hargreaves KM (1998) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345: 145-153

Richardson JD, Aanonsen L, Hargreaves KM (1998) Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci 18: 451-457

Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111-119

Richardson PJ (2001) The adenosine A(2A) receptor of the basal ganglia. J Physiol 532: 284

Richter A, Loscher W (2002) Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. Eur J Pharmacol 454: 145-151

Richter TA, Spackman DS, Robinson JE, Dye S, Harris TG, Skinner DC, Evans NP (2001) Role of endogenous opioid peptides in mediating progesterone-induced disruption of the activation and transmission stages of the GnRH surge induction process. Endocrinology 142: 5212-5219

Rickman C, Archer DA, Meunier FA, Craxton M, Fukuda M, Burgoyne RD, Davletov B (2004) Synaptotagmin interaction with the syntaxin/SNAP-25 dimer is mediated by an evolutionarily conserved motif and is sensitive to inositol hexakisphosphate. J Biol Chem 279: 12574-12579

Rickman C, Craxton M, Osborne S, Davletov B (2004) Comparative analysis of tandem C2 domains from the mammalian synaptotagmin family. Biochem J 378: 681-686

Rickman C, Davletov B (2003) Mechanism of calcium-independent synaptotagmin binding to target SNAREs. J Biol Chem 278: 5501-5504

Rickman C, Meunier FA, Binz T, Davletov B (2004) High affinity interaction of syntaxin and SNAP-25 on the plasma membrane is abolished by botulinum toxin E. J Biol Chem 279: 644-651

Rickman DW (1999) Parvalbumin immunoreactivity is enhanced by brain-derived neurotrophic factor in organotypic cultures of rat retina. J Neurobiol 41: 376-384

Riegel AC, Williams JT, Lupica CR (2003) Cannabinoid CB1 receptors inhibit GABA-B mediated synaptic currents in midbrain dopamine neurons. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Riley AM, Morris SA, Nerou EP, Correa V, Potter BV, Taylor CW (2002) Interactions of inositol 1,4,5-trisphosphate (IP(3)) receptors with synthetic poly(ethylene glycol)-linked dimers of IP(3) suggest close spacing of the IP(3)-binding sites. J Biol Chem 277: 40290-40295

Rimondini R, Arlinde C, Sommer W, Heilig M (2002) Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. Faseb J 16: 27-35

Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Perio A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrie P, Le Fur G (2004) SR147778, a new potent and selective antagonist of the CB1 cannabinoid receptor. Biochemical and pharmacological characterization. J Pharmacol Exp Ther

Rinaldi-Carmona M, Barth F, Heaulme M, Alonso R, Shire D, Congy C, Soubrie P, Breliere JC, Le Fur G (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56: 1941-1947

Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244

Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284: 644-650

Rinaldi-Carmona M, Calandra B, Shire D, Bouaboula M, Oustric D, Barth F, Casellas P, Ferrara P, Le Fur G (1996) Characterization of two cloned human CB1 cannabinoid receptor isoforms. J Pharmacol Exp Ther 278: 871-878

Rinaldi-Carmona M, Le Duigou A, Oustric D, Barth F, Bouaboula M, Carayon P, Casellas P, Le Fur G (1998) Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. J Pharmacol Exp Ther 287: 1038-1047

Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, Breliere JC, Soubrie P, Le Fur G (1996) Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci 58: 1239-1247

Rismondo V, Osgood TB, Leering P, Hattenhauer MG, Ubels JL, Edelhauser HF (1989) Electrolyte composition of lacrimal gland fluid and tears of normal and vitamin A-deficient rabbits. Clao J 15: 222-228

Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, Lamsa K, Pirvola U, Saarma M, Kaila K (1999) The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397: 251-255

Robbe D, Alonso G, Manzoni OJ (2003) Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann N Y Acad Sci 1003: 212-225

Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A 99: 8384-8388

Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380

Roberts LA, Christie MJ, Connor M (2002) Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137: 421-428

Roberts SL, Furlan RL, Cousins GR, Sanders JK (2002) Simultaneous selection, amplification and isolation of a pseudo-peptide receptor by an immobilised N-methyl ammonium ion template. Chem Commun (Camb): 938-939

Roberts SL, Furlan RL, Otto S, Sanders JK (2003) Metal-ion induced amplification of three receptors from dynamic combinatorial libraries of peptide-hydrazones. Org Biomol Chem 1: 1625-1633

Robin P, Rossignol B, Raymond MN (1996) Recovery of protein secretion after brefeldin A treatment of rat lacrimal glands: effect of cAMP. Am J Physiol 271: C783-793

Robin P, Rossignol B, Raymond MN (1998) PKA inhibitor, H-89, affects the intracellular transit of regulated secretory proteins in rat lacrimal glands. Am J Physiol 274: C262-271

Robinson JE, Birch RA, Grindrod JA, Taylor JA, Unsworth WP (2003) Sexually differentiated regulation of gnRH release by gonadal steroid hormones in sheep. Reprod Suppl 61: 299-310

Robinson L, Hinder L, Pertwee RG, Hampson RE, Riedel G (2003) Differential effects of systemic and intracranial cannabinoid infusion on spatial short - term memory in rats. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Robinson L, Kelly EA, Riedel G, Hampson RE (2002) Site - Directed Infusion of Cannabinoids Alter Hippocampus - Dependent Learning and Ensemble Coding in Rats. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002

Robinson L, Pertwee R, Riedel G (2000) Novel visual acuity test for the water maze: Importance of cholinergic and endocannabinoid system. Journal of Physiology (Cambridge) 528P

Roch F, Jimenez G, Casanova J (2002) EGFR signalling inhibits Capicua-dependent repression during specification of Drosophila wing veins. Development 129: 993-1002

Roche JP, Bounds S, Brown S, Mackie K (1999) A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization. Mol Pharmacol 56: 611-618

Roderick HL, Bootman MD (2003) Bi-directional signalling from the InsP3 receptor: regulation by calcium and accessory factors. Biochem Soc Trans 31: 950-953

Roderick HL, Bootman MD (2003) Calcium influx: is Homer the missing link? Curr Biol 13: R976-978

Rodgers RJ, Haller J, Halasz J, Mikics E (2003) 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze. Eur J Neurosci 17: 1279-1286

Rodgers RJ, Haller J, Halasz J, Mikics E, Baird CL, Cohen SL (2003) Differential effects of cannabinoid receptor antagonist, SR141716A, on trial 1 & trial 2 plus-maze anxiety in mice. Journal of Psychopharmacology 17

Rodriguez de Fonseca F, Del Arco I, Martin-Calderon JL, Gorriti MA, Navarro M (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 5: 483-501

Rodriguez De Fonseca F, Gorriti MA, Bilbao A, Escuredo L, Garcia-Segura LM, Piomelli D, Navarro M (2001) Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia. Neurotox Res 3: 23-35

Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D (2001) An anorexic lipid mediator regulated by feeding. Nature 414: 209-212

Rodriguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, Navarro M (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Zhongguo Yao Li Xue Bao 20: 1109-1114

Rodriguez de Fonseca F, Wenger T, Navarro M, Murphy LL (1999) Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells. Brain Res 841: 114-122

Rodriguez de Fonseca FR, Villanua MA, Munoz RM, San-Martin-Clark O, Navarro M (1995) Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats. Neuroendocrinology 61: 714-721

Rodriguez JJ, Mackie K, Pickel VM (2001) Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci 21: 823-833

Rogers C, Reale V, Kim K, Chatwin H, Li C, Evans P, de Bono M (2003) Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1. Nat Neurosci 6: 1178-1185

Rohrbough J, Spitzer NC (1999) Ca(2+)-permeable AMPA receptors and spontaneous presynaptic transmitter release at developing excitatory spinal synapses. J Neurosci 19: 8528-8541

Roitenburd Belacortu V (1985) [Effect of thioacetamide on the rat liver under various conditions of protein supplementation to the diet]. Rev Invest Clin 37: 303-310

Romero J, Berrendero F, Garcia-Gil L, Lin SY, Makriyannis A, Ramos JA, Fernandez-Ruiz JJ (1999) Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide. Neurochem Int 34: 473-482

Romero J, Berrendero F, Perez-Rosado A, Manzanares J, Rojo A, Fernandez-Ruiz JJ, de Yebenes JG, Ramos JA (2000) Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen. Life Sci 66: 485-494

Romero J, de Miguel R, Garcia-Palomero E, Fernandez-Ruiz JJ, Ramos JA (1995) Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res 694: 223-232

Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ (1997) Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26: 317-323

Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ (1997) Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res 46: 100-108

Romero J, Garcia-Palomero E, Lin SY, Ramos JA, Makriyannis A, Fernandez-Ruiz JJ (1996) Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sci 58: 1249-1257

Romero J, Garcia L, Cebeira M, Zadrozny D, Fernandez-Ruiz JJ, Ramos JA (1995) The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci 56: 2033-2040

Romero J, Garcia L, Fernandez-Ruiz JJ, Cebeira M, Ramos JA (1995) Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 51: 731-737

Romero J, Hillard CJ, Calero M, Rabano A (2002) Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res 100: 85-93

Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernandez-Ruiz J (2002) The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. Pharmacol Ther 95: 137-152

Ronesi J, Gerdeman GL, Lovinger DM (2003) Timing and cellular source of release of endocannabinoids necessary for striatal LTD. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003

Ronesi J, Gerdeman GL, Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24: 1673-1679

Roomans GM (1984) X-ray microanalysis of rat exorbital lacrimal gland. Scan Electron Microsc: 889-895

Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, Martin-Ruiz R, Arroyo V, Rivera F, Rodes J, Jimenez W (2002) Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122: 85-93

Rosado JA, Porras T, Conde M, Sage SO (2001) Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. J Biol Chem 276: 15666-15675

Rosado JA, Sage SO (2000) Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted. Biochem J 350 Pt 3: 631-635

Rosado JA, Sage SO (2000) Protein kinase C activates non-capacitative calcium entry in human platelets. J Physiol 529 Pt 1: 159-169

Rosado JA, Sage SO (2001) Activation of store-mediated calcium entry by secretion-like coupling between the inositol 1,4,5-trisphosphate receptor type II and human transient receptor potential (hTrp1) channels in human platelets. Biochem J 356: 191-198

Rosenberry TL, Roberts WL, Haas R (1986) Glycolipid membrane-binding domain of human erythrocyte acetylcholinesterase. Fed Proc 45: 2970-2975

Roshak AK, Capper EA, Stevenson C, Eichman C, Marshall LA (2000) Human calcium-independent phospholipase A2 mediates lymphocyte proliferation. J Biol Chem 275: 35692-35698

Rosler M (2002) The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract Suppl: 20-36

Ross BM, Kim DK, Bonventre JV, Kish SJ (1995) Characterization of a novel phospholipase A2 activity in human brain. J Neurochem 64: 2213-2221

Ross CA, Danoff SK, Schell MJ, Snyder SH, Ullrich A (1992) Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci U S A 89: 4265-4269

Ross RA (2003) Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 140: 790-801

Ross RA, Brockie HC, Fernando SR, Saha B, Razdan RK, Pertwee RG (1998) Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine. Br J Pharmacol 125: 1345-1351

Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 126: 665-672

Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, MacEwan DJ, Scott RH (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40: 221-232

Ross RA, Craib SJ, Stevenson LA, Pertwee RG, Henderson A, Toole J, Ellington HC (2002) Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J Pharmacol Exp Ther 301: 900-907

Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG (2001) Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br J Pharmacol 132: 631-640

Ross RA, Gibson TM, Stevenson LA, Saha B, Crocker P, Razdan RK, Pertwee RG (1999) Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors. Br J Pharmacol 128: 735-743

Roth MD, Baldwin GC, Tashkin DP (2002) Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids 121: 229-239

Rouach N, Nicoll RA (2003) Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. Eur J Neurosci 18: 1017-1020

Rouzer CA, Ghebreselasie K, Marnett LJ (2002) Chemical stability of 2-arachidonylglycerol under biological conditions. Chem Phys Lipids 119: 69-82

Rowland NE, Mukherjee M, Robertson K (2001) Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology (Berl) 159: 111-116

Royle SJ, Bobanovic LK, Murrell-Lagnado RD (2002) Identification of a non-canonical tyrosine-based endocytic motif in an ionotropic receptor. J Biol Chem 277: 35378-35385

Rubino T, Massi P, Vigano D, Fuzio D, Parolaro D (2000) Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome. Life Sci 66: 2213-2219

Rubino T, Patrini G, Massi P, Fuzio D, Vigano D, Giagnoni G, Parolaro D (1998) Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J Pharmacol Exp Ther 285: 813-819

Rubino T, Tizzoni L, Vigano D, Massi P, Parolaro D (1997) Modulation of rat brain cannabinoid receptors after chronic morphine treatment. Neuroreport 8: 3219-3223

Rubino T, Vigano D, Costa B, Colleoni M, Parolaro D (2000) Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. J Neurochem 75: 2478-2484

Rubino T, Vigano D, Massi P, Parolaro D (2003) Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization. Eur J Neurosci 17: 325-330

Rubino T, Vigano D, Massi P, Spinello M, Zagato E, Giagnoni G, Parolaro D (2000) Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology 39: 1331-1336

Rubino T, Vigano D, Zagato E, Sala M, Parolaro D (2000) In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments. Synapse 35: 8-14

Rubovitch V, Gafni M, Sarne Y (2002) The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells. Brain Res Mol Brain Res 101: 93-102

Rubovitch V, Gafni M, Sarne Y (2004) The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells. Brain Res Mol Brain Res 120: 138-144

Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW (2002) Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525

Rudge EU, Cutler AJ, Pritchard NR, Smith KG (2002) Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression. J Exp Med 195: 1079-1085

Rudling JE, Richardson J, Evans PD (2000) A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes. Br J Pharmacol 131: 933-941

Rueda D, Galve-Roperh I, Haro A, Guzman M (2000) The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58: 814-820

Rueda D, Navarro B, Martinez-Serrano A, Guzman M, Galve-Roperh I (2002) The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J Biol Chem 277: 46645-46650

Rueda P, Quiroz-Torres AM, Martinez-Vargas M, Prospero-Garcia O (2002) Endocannabinoid Effects on Memory Depend on Diurnal Variations. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002

Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L (2003) Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 306: 363-370

Ruiz-Llorente L, Ortega-Gutierrez S, Viso A, Sanchez MG, Sanchez AM, Fernandez C, Ramos JA, Hillard C, Lasuncion MA, Lopez-Rodriguez ML, Diaz-Laviada I (2004) Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Br J Pharmacol 141: 457-467

Ruiz-Llorente L, Sanchez MG, Carmena MJ, Prieto JC, Sanchez-Chapado M, Izquierdo A, Diaz-Laviada I (2003) Expression of functionally active cannabinoid receptor CB1 in the human prostate gland. Prostate 54: 95-102

Rukwied R, Watkinson A, McGlone F, Dvorak M (2003) Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain 102: 283-288

Runft LL, Watras J, Jaffe LA (1999) Calcium release at fertilization of Xenopus eggs requires type I IP(3) receptors, but not SH2 domain-mediated activation of PLCgamma or G(q)-mediated activation of PLCbeta. Dev Biol 214: 399-411

Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD (1999) 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30: 1665-1670

Russo E (1998) Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain 76: 3-8

Rutter GA, Rizzuto R (2000) Regulation of mitochondrial metabolism by ER Ca2+ release: an intimate connection. Trends Biochem Sci 25: 215-221

Ryan WJ, Banner WK, Wiley JL, Martin BR, Razdan RK (1997) Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. J Med Chem 40: 3617-3625